Feeds › Capitol Hires
Capitol Hires
Lobbyists whose filings say they once worked in a member of Congress' office, on a committee or in the executive branch, with the public company that hired them.
About this data
- What it is
- Capitol Hires lists lobbyists who say, in a filing under the Lobbying Disclosure Act, that they once held a government job: in a member of Congress’ office, on a congressional committee or in the executive branch. Each row names the public company that hired the lobbyist (directly or through a lobbying firm), the office they came from and the job they held there.
- Who files it
- The lobbying firm (or the company, for its own lobbyists) on each quarterly report (LD-2) and registration (LD-1) it files with the Senate and the House.
- How current
- New filings are posted every day. We read each one the day after it is posted.
- Terms
- Covered positionA covered position is a job in the federal government that a lobbyist held in the 20 years before the filing: in the office of a member of Congress, on a committee, or in the executive branch. The Lobbying Disclosure Act asks the lobbyist to name it.As writtenThe office, the member and the job title are shown as the registrant typed them. A short job title such as LD or CoS is not spelled out.Linked memberA member is linked to their page only when exactly one member of Congress fits the name, the chamber, the first name and the years given. Otherwise the name is shown as written, without a link.FilingsThe same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one.
- Worth knowing
- Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The text is free-form, so we read it by rules and some offices are missed or misread. Check the filing before relying on one row. A member is linked only on a unique match, and many are not: those are shown as written. Company matching is automatic and can miss a subsidiary. Information, not investment advice.
All of this comes from lobbying disclosure filings that the Senate and the House publish.
Information, not investment advice (disclaimer). Where this data comes from.
Latest Capitol Hires
| The covered position the lobbyist says they held: an office of a member of Congress, a committee or an executive-branch body, as written in the filing. The member's name is a link only when exactly one member of Congress fits the name, chamber, first name and years given; otherwise it stays as written. | The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them. | ||||
|---|---|---|---|---|---|
| MRNA Moderna, Inc. | William Dolbow | Eric Cantor Member office · Republican-VA · 2011–2013 | Senior Advisor | DGSR LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| MRNA Moderna, Inc. | William Dolbow | Cantor (House) Member office · House · 2001–2004 | LD | DGSR LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| MRNA Moderna, Inc. | William Dolbow | Tom Bliley (House) Member office · House · 1998–2001 | Press Sec/Leg. Director | DGSR LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| MRNA Moderna, Inc. | William Dolbow | Bliley (House) Member office · House · 1994–1998 | LA | DGSR LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| MRNA Moderna, Inc. | Gayle Gerdes | Timothy Hutchison (Senate) Member office · Senate | Legislative Correspondent | Health Policy Source, Inc. | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| MRNA Moderna, Inc. | Gayle Gerdes | Chris John (House) Member office · House | Legislative Assistant | Health Policy Source, Inc. | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| MRNA Moderna, Inc. | Gayle Gerdes | Jim McCrery (House) Member office · House | Intern | Health Policy Source, Inc. | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| MRNA Moderna, Inc. | Gayle Gerdes | Cleo Fields Member office · Democrat-LA | Intern | Health Policy Source, Inc. | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| MRNA Moderna, Inc. | Valerie Henry | Greg Walden Member office · Republican-OR | Legislative Director | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| MRNA Moderna, Inc. | Valerie Henry | John Warner (Senate) Member office · Senate | Legislative Assistant | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| MRNA Moderna, Inc. | Valerie Henry | Mike Crapo Member office · Republican-ID | Legislative Assistant | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| MRNA Moderna, Inc. | James Derderian | House Commerce Committee Committee | Chief of Staff | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| MRNA Moderna, Inc. | James Derderian | Tom Bliley (House) Member office · House | Legislative Advisor | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| MRNA Moderna, Inc. | Bryan Wells | Pat Roberts Member office · Republican-KS | Policy Advisor | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| MRNA Moderna, Inc. | Aisling McDonough | Anna G. Eshoo Member office · Democrat-CA | Senior Health Advisor | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 7 filings |
| MRNA Moderna, Inc. | Aisling McDonough | Commerce Committee Committee | Policy Coordinator, Energy | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 7 filings |
| MRNA Moderna, Inc. | Aisling McDonough | Brian Schatz Member office · Democrat-HI | Legislative Assistant | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 7 filings |
| MRNA Moderna, Inc. | Kevin Dawson | Mike Kelly Member office · Republican-PA | Chief of Staff | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 3 filings |
| MRNA Moderna, Inc. | Kevin Dawson | Bill Cassidy Member office · Republican-LA | Health Policy Advisor | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 3 filings |
| MRNA Moderna, Inc. | Kevin Dawson | Senate Committee on the Budget Committee | Professional Staff Member | Stanton Park Group | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 3 filings |
| MRNA Moderna, Inc. | John Reising | Steve Scalise Member office · Republican-LA | Scheduler, Operations Director, Member Services Director, Deputy Chief of Staff | Brownstein Hyatt Farber Schreck, LLP | Report period 2026 Q3 ↗ Posted Oct 20, 2026 |
| MRNA Moderna, Inc. | John Reising | Bill Flores Member office · Republican-TX | Operations Director | Brownstein Hyatt Farber Schreck, LLP | Report period 2026 Q3 ↗ Posted Oct 20, 2026 |
| MRNA Moderna, Inc. | John Reising | Austin Scott Member office · Republican-GA | Scheduler | Brownstein Hyatt Farber Schreck, LLP | Report period 2026 Q3 ↗ Posted Oct 20, 2026 |
| MRNA Moderna, Inc. | John Reising | Trent Lott (Senate) Member office · Senate | Intern | Brownstein Hyatt Farber Schreck, LLP | Report period 2026 Q3 ↗ Posted Oct 20, 2026 |
| MRNA Moderna, Inc. | Gregory Nickerson | Ways and Means Committee Committee | Tax Counsel | The Washington Tax & Public Policy Group | Report period 2026 Q3 ↗ Posted Oct 15, 2026 · in 8 filings |
| MRNA Moderna, Inc. | Gregory Nickerson | Ways and Means Select Revenue Measures Subcommittee Committee | Staff Director | The Washington Tax & Public Policy Group | Report period 2026 Q3 ↗ Posted Oct 15, 2026 · in 8 filings |
| MRNA Moderna, Inc. | Zachary Price | Daniel Coats Member office · Republican-IN | Staff Assistant | The Washington Tax & Public Policy Group | Report period 2026 Q3 ↗ Posted Oct 15, 2026 · in 8 filings |
| MRNA Moderna, Inc. | James Pedrotti | Carol D. Miller Member office · Republican-WV | Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Deputy Chief of Staff | The Washington Tax & Public Policy Group | Report period 2026 Q3 ↗ Posted Oct 15, 2026 · in 6 filings |
| MRNA Moderna, Inc. | Daniel Boston | House Energy & Commerce Committee | Health Policy Director | Health Policy Source, Inc. | Report period 2026 Q1 ↗ Posted Apr 15, 2026 · in 7 filings |
| MRNA Moderna, Inc. | Daniel Boston | Sue Kelly (House) Member office · House | Deputy Chief of Staff & Spokesperson | Health Policy Source, Inc. | Report period 2026 Q1 ↗ Posted Apr 15, 2026 · in 7 filings |
| MRNA Moderna, Inc. | Daniel Boston | Joe Knollenberg (House) Member office · House | Policy Advisory &Communications Director | Health Policy Source, Inc. | Report period 2026 Q1 ↗ Posted Apr 15, 2026 · in 7 filings |
| MRNA Moderna, Inc. | Daniel Boston | Mitch McConnell Member office · Republican-KY | Communications Advisor | Health Policy Source, Inc. | Report period 2026 Q1 ↗ Posted Apr 15, 2026 · in 7 filings |
| MRNA Moderna, Inc. | Sarah Curtis | Manning (House) Member office · House | Chief of Staff | Moderna, Inc. | Report period 2025 Q3 ↗ Posted Mar 23, 2026 |
| MRNA Moderna, Inc. | Sarah Curtis | Kennedy (House) Member office · House | Deputy Chief of Staff | Moderna, Inc. | Report period 2025 Q3 ↗ Posted Mar 23, 2026 |
| MRNA Moderna, Inc. | Sarah Curtis | Chandler (House) Member office · House | Legislative Director | Moderna, Inc. | Report period 2025 Q3 ↗ Posted Mar 23, 2026 |
| MRNA Moderna, Inc. | Sarah Curtis | Driehaus (House) Member office · House | Legislative Director | Moderna, Inc. | Report period 2025 Q3 ↗ Posted Mar 23, 2026 |
| MRNA Moderna, Inc. | Sarah Curtis | Strickland (House) Member office · House | Legislative Assistant | Moderna, Inc. | Report period 2025 Q3 ↗ Posted Mar 23, 2026 |
| MRNA Moderna, Inc. | Andrew Siracuse | John Cornyn Member office · Republican-TX | Sr. Tax Cnsl | Holland & Knight LLP | Report period 2025 Q3 ↗ Posted Oct 15, 2025 |
| MRNA Moderna, Inc. | Andrew Siracuse | Sen. Fin. Cmte Committee | Staff Dir. , Energy, Nat. Res. Sbcmte | Holland & Knight LLP | Report period 2025 Q3 ↗ Posted Oct 15, 2025 |
| MRNA Moderna, Inc. | Andrew Siracuse | Cornyn (Senate) Member office · Senate | LA | Holland & Knight LLP | Report period 2025 Q3 ↗ Posted Oct 15, 2025 |
| MRNA Moderna, Inc. | Andrew Siracuse | Norm Coleman (Senate) Member office · Senate | LA | Holland & Knight LLP | Report period 2025 Q3 ↗ Posted Oct 15, 2025 |
| MRNA Moderna, Inc. | Matthew Fuentes | Charles E. Schumer Member office · Democrat-NY | Legislative Aide | Avenue Solutions | Report period 2025 Q2 ↗ Posted Jul 21, 2025 |
| MRNA Moderna, Inc. | Matthew Fuentes | Senate Finance Committee Committee | Research Assistant - ( | Avenue Solutions | Report period 2025 Q2 ↗ Posted Jul 21, 2025 |
| MRNA Moderna, Inc. | Matthew Fuentes | Ron Wyden Member office · Democrat-OR | Research Assistant - ( | Avenue Solutions | Report period 2025 Q2 ↗ Posted Jul 21, 2025 |
| MRNA Moderna, Inc. | Joshua Odintz | Senate Finance Committee Committee | Tax Counsel | Holland & Knight LLP | Report period 2025 Q1 ↗ Posted Mar 6, 2025 |
| MRNA Moderna, Inc. | Andrew Usyk | Robert P. Casey, Jr. Member office · Democrat-PA | Leg Assistant | Brownstein Hyatt Farber Schreck, LLP | Report period 2024 Q4 ↗ Posted Jan 21, 2025 |
| MRNA Moderna, Inc. | Andrew Usyk | Kristen Gillibrand (Senate) Member office · Senate | Legislative Correspondent | Brownstein Hyatt Farber Schreck, LLP | Report period 2024 Q4 ↗ Posted Jan 21, 2025 |
| MRNA Moderna, Inc. | Andrew Usyk | Gillibrand (Senate) Member office · Senate | Intern | Brownstein Hyatt Farber Schreck, LLP | Report period 2024 Q4 ↗ Posted Jan 21, 2025 |
| MRNA Moderna, Inc. | Andrew Usyk | John D. Dingell Member office · Democrat-MI | Intern | Brownstein Hyatt Farber Schreck, LLP | Report period 2024 Q4 ↗ Posted Jan 21, 2025 |
The newest 49 of 49 matching. Narrow them with the filters above.
Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one. Updated Nov 15, 2026, 6:03 PM EST.